Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome

Authors not listed

Acibadem University · 2021

Abstract

Sarcopenia is a progressive condition characterized by decline in muscle strength and muscle mass. Although the mechanism of sarcopenia has not been fully elucidated, it may be caused by protein-poor diet, vitamin D deficiency, hormonal changes, increase in inflammatory cytokine level and oxidative stress. For this reason, it is thought that determining the prevalence of sarcopenia in rheumatological diseases with chronic inflammation and protecting patients from possible comorbidities with appropriate interventions may be an important factor in maintaining and improving the functional levels and quality of life of patients. The aim of our study was to investigate the prevalence and its associated factors of sarcopenia in individuals with primary Sjögren's Syndrome.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Anonymous. (2021). Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome. <em>Acibadem University</em>. https://clinicaltrials.gov/study/NCT05015114
Vancouver
Anonymous. Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome. Acibadem University. 2021.
BibTeX
@misc{anon2021Preval, title = {Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome}, author = {Anonymous}, journal = {Acibadem University}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings